A novel bed-side measure of brain condition and function

Cerenion Oy develops the world’s first practical method for measuring the brain function of intensive care patients. Our Cerenion ART™ technology (pat. pend.) aims to reveal the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient.
The solution works by combining state-of-the-art signal analysis technology with standard electroencephalogram (EEG) measurement and the common pharmacological compounds used in intensive care today.
The technology has the potential of improving both the quality and the cost of intensive care.

About us

Cerenion Oy is a science-based university spin-off that develops technology for the measurement of brain function for diagnostic and therapeutic purposes in medicine.

Would you like to know more?

We would be happy to tell you more about our technology, and talk about possible avenues of collaboration. So please don't hesitate to contact us for more information.

Contact us

Dr. Timo Koskela, CEO
tel. +358 40 5773 706
e-mail

Visit us

Cerenion Oy
Paavo Havaksen tie 5C
90570 Oulu
FINLAND
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Under no circumstances shall the information on this website be construed as an advertisement of any commercially available product. Cerenion™, Cerenion ART™, ART™ and ''The pulse of the brain''™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2017.